Evidence map›Paper›PMID 42141023›Full record

ArticleScientific reports2026

Mesoporous silica nanoparticles functionalized with folic acid and zinc for enhanced targeted delivery of daunorubicin to breast cancer cells.

Seyedeh Elaheh Sheykholeslami, Nasim Kaveh Farsani, Yeganeh Azari Incheh Sablagh, Soheil Afshari-BehbahaniZadeh, Mohammadhosein Keshvadi, Fatemeh Najafi, Hassan Noorbazargan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seyedeh Elaheh Sheykholeslami *Borna Bioscience Institute, Tehran, Iran.
Nasim Kaveh Farsani *Department of Chemical Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran.
Yeganeh Azari Incheh Sablagh *Department of Biology, CT.C, Islamic Azad University, Tehran, Iran.
Soheil Afshari-BehbahaniZadehFaculty of Veterinary Medicine, Azad University of Garmsar, Garmsar, Iran.
Mohammadhosein KeshvadiFaculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh NajafiDepartment of Chemical Engineering, Amirkabir University of Technology (Tehran Polytechnic), No. 424, Hafez Ave., P.O. Box, Tehran, 15875-4413, Iran.
Hassan NoorbazarganDepartment of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. h.noorbazargan@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted delivery of therapeutic agents may enhance anticancer efficacy through specific mechanisms. We have developed and characterized folic acid-functionalized mesoporous silica nanoparticles with co-loaded Daunorubicin and Zn

Indexed as

Breast NeoplasmsDaunorubicinFolic AcidNanoparticlesSilicon DioxideZincApoptosisCell SurvivalDrug CarriersDrug Delivery SystemsDrug LiberationFemaleHumansMCF-7 CellsPorosityDaunorubicinDrug CarriersFolic AcidSilicon DioxideZincBreast cancerDrug delivery systemGene regulationMesoporous silica nanoparticlesSynergy

Identifiers

PMID42141023
PMCPMC13369930

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.